Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak KE, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Payami H, Molho E, Factor SA, Nutt JG, Serrano C, Arroyo M, Ottman R, Pauciulo MW, Nichols WC, Clark LN, Marder KS.

JAMA Neurol. 2014 Jan;71(1):62-7. doi: 10.1001/jamaneurol.2013.4498.

2.

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN.

J Mol Neurosci. 2012 May;47(1):139-43. doi: 10.1007/s12031-011-9696-y. Epub 2011 Dec 23.

3.

Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.

Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, Lee JH.

BMC Med Genet. 2011 Aug 3;12:104. doi: 10.1186/1471-2350-12-104.

4.

Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.

Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Cote LJ, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Siderowf AD, Ross BM, Verbitsky M, Kisselev S, Ottman R, Clark LN, Marder KS.

J Int Neuropsychol Soc. 2011 Jan;17(1):91-100. doi: 10.1017/S1355617710001190. Epub 2010 Nov 24.

5.

Total knee arthroplasty and Parkinson disease: enhancing outcomes and avoiding complications.

Macaulay W, Geller JA, Brown AR, Cote LJ, Kiernan HA.

J Am Acad Orthop Surg. 2010 Nov;18(11):687-94. Review.

PMID:
21041803
6.

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN.

Arch Neurol. 2010 Jun;67(6):731-8. doi: 10.1001/archneurol.2010.95.

7.

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.

Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Ottman R, Clark LN, Marder KS, Caccappolo E.

J Clin Exp Neuropsychol. 2010 Aug;32(7):775-9. doi: 10.1080/13803390903521018. Epub 2010 Feb 24.

8.

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Caccappolo E, Ottman R, Clark LN, Marder KS.

Arch Neurol. 2009 Dec;66(12):1517-22. doi: 10.1001/archneurol.2009.267.

9.

Association of glucocerebrosidase mutations with dementia with lewy bodies.

Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K.

Arch Neurol. 2009 May;66(5):578-83. doi: 10.1001/archneurol.2009.54.

10.

Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.

Wang Y, Clark LN, Louis ED, Mejia-Santana H, Harris J, Cote LJ, Waters C, Andrews H, Ford B, Frucht S, Fahn S, Ottman R, Rabinowitz D, Marder K.

Arch Neurol. 2008 Apr;65(4):467-74. doi: 10.1001/archneur.65.4.467.

11.

Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene.

Clark LN, Haamer E, Mejia-Santana H, Harris J, Lesage S, Durr A, Bs SJ, Hedrich K, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Scott W, Klein C, Brice A, Roomere H, Ottman R, Marder K.

Mov Disord. 2007 May 15;22(7):932-7.

PMID:
17415800
12.

Case-control study of the parkin gene in early-onset Parkinson disease.

Clark LN, Afridi S, Karlins E, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Arch Neurol. 2006 Apr;63(4):548-52.

PMID:
16606767
13.

Visual search deficits in Parkinson's disease are attenuated by bottom-up target salience and top-down information.

Horowitz TS, Choi WY, Horvitz JC, Côté LJ, Mangels JA.

Neuropsychologia. 2006;44(10):1962-77. Epub 2006 Mar 31.

PMID:
16580700
14.

Maintenance of response readiness in patients with Parkinson's disease: evidence from a simple reaction time task.

Stern ER, Horvitz JC, Côté LJ, Mangels JA.

Neuropsychology. 2005 Jan;19(1):54-65.

PMID:
15656763
15.

Disparities in the recording of Parkinson's disease on death certificates.

Pressley JC, Tang MX, Marder K, Cote LJ, Mayeux R.

Mov Disord. 2005 Mar;20(3):315-21.

PMID:
15580618
16.

Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity.

Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Mayeux R, Ottman R, Marder K.

Mov Disord. 2005 Jan;20(1):100-3.

PMID:
15517591
17.

Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations.

Clark LN, Afridi S, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Singleton A, Wavrant De-Vrieze F, Hardy J, Mayeux R, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Mov Disord. 2004 Jul;19(7):796-800. doi: 10.1002/mds.20131.

PMID:
15254937
18.

The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts.

Clark LN, Levy G, Tang MX, Mejia-Santana H, Ciappa A, Tycko B, Cote LJ, Louis ED, Mayeux R, Marder K.

Neurosci Lett. 2003 Aug 14;347(1):17-20.

PMID:
12865131
19.

Memory and executive function impairment predict dementia in Parkinson's disease.

Levy G, Jacobs DM, Tang MX, Côté LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K.

Mov Disord. 2002 Nov;17(6):1221-6.

PMID:
12465060
20.

The Mortal Stage of late life.

Forrest DV, Côté LJ.

J Am Acad Psychoanal. 2002 Fall;30(3):329-40.

PMID:
12389510

Supplemental Content

Loading ...
Support Center